09:14 AM EST, 12/24/2024 (MT Newswires) -- Trinity Biotech ( TRIB ) said Tuesday it has secured $5.5 million in additional liquidity through amended agreements with Perceptive Advisors, including cash and payment-in-kind interest.

As part of the agreement, Trinity has granted Perceptive 1.5 million additional warrants to buy its American depositary shares and repriced its existing warrants to $0.80 per ADS, Trinity added.

A $5 million deferred payment tied to its acquisition of Waveform Technologies assets was also extended to November 2025, increasing its financial flexibility, Trinity Biotech ( TRIB ) said.

The liquidity will support the company's transformation plan, including its World Health Organization-approved transition to offshore manufacturing for TrinScreen HIV and Uni-Gold HIV, Trinity Biotech ( TRIB ) said.

Trinity Biotech ( TRIB ) were up more than 10% in recent premarket activity.